<DOC>
	<DOCNO>NCT02268006</DOCNO>
	<brief_summary>RATIONALE : Using small radiation beamlets different intensity , IMRT ( intensity modulate radiation therapy ) allow shape dose around plan target volume well spar normal tissue compare 3D conformal radiotherapy . It allow daily delivery high dose tumor simultaneous integrate boost ( SIB ) , consequently shorten total treatment time potentially well response treatment . In advanced rectal adenocarcinoma excellent response preoperative radiochemotherapy complete eradication primary tumor observe histopathological specimen ( pathological complete response , pCR ) correlate favorable overall prognosis , try achieve well response preoperative treatment high pCR seams feasible . PURPOSE : The hypothesis study preoperative radiochemotherapy locally advance rectal adenocarcinoma shorten total treatment time IMRT-SIB 22 daily fraction concomitant capecitabine result improve pCR rate 9 % ( Slovenian trial ) 25 % . Secondary objective evaluate pathological down-staging rate , histopathological R0 resection rate , sphincter preservation rate , perioperative surgical complication rate , local control , disease-free survival ( DFS ) , overall survival ( OS ) , late toxicity quality life .</brief_summary>
	<brief_title>IMRT-SIB Capecitabine Preoperative Rectal Cancer Treatment</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Biopsyproven newly diagnose primary rectal adenocarcinoma Locally advance tumor fulfil least one follow criterion pelvic MRI : T ≥ 3 N ≥ 1 Positive mesorectal fascia ( MRF ) , i.e . tumor lymph node one mm less mesorectal fascia Tumor locate od 0 15 cm anocutaneous junction peritoneum Age 18 year Signed informed consent WHO Performance Status 02 Patients consider mentally physically ft chemotherapy judge oncologist Adequate hematological , hepatic renal function ( WBC ≥ 3.0 x 109/L , neu ≥ 1.5 x 109/L , platelet count ≥ 100 x 109/L , renal clearance ≥ 50 ml/min , bilirubin ≤ 3x normal value , aspartate transaminase/alanine transaminase ( AST/ALT ) ≤ 2,5x normal value ) T4 inoperable tumor extensive growth cranial part sacrum ( S3 ) lumbosacral nerve root Metastatic recurrent rectal cancer Other coexist malignancy malignancy within past 5 year , exception adequately treat situ carcinoma cervix basal cell carcinoma skin Chronic bowel inflammatory disease Pregnant lactating patient Significant heart disease ( uncontrolled hypertension despite medication ( &gt; 150/100 mmHg ) , New York Heart Association ( NYHA ) class III IV heart disease , unstable angina myocardial infarction within past 1 year prior study entry , history significant ventricular arrhythmia require treatment ) Inability consciously sign consent form due physical psychological disability</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>rectal carcinoma</keyword>
	<keyword>preoperative radiochemotherapy</keyword>
	<keyword>IMRT</keyword>
	<keyword>SIB</keyword>
</DOC>